查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451268

2024-2032 年他汀类药物市场报告（按类型、治疗领域、药物类别、应用、分布和地区）

Statin Market Report by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2023年全球他汀类药物市场规模达154亿美元。展望未来， IMARC Group预计到2032年市场规模将达到200亿美元，2024-2032年复合年增长率（CAGR）为2.9%。由于全球心血管疾病和高胆固醇血症的盛行率不断上升、医疗基础设施的扩大以及降胆固醇药物保险范围的扩大，刺激了全球需求，该市场正在经历稳定增长。

他汀类药物市场分析：

市场成长与规模：全球市场正在经历显着成长，这主要是由于心血管疾病盛行率的不断上升所推动的。随着降胆固醇药物需求的不断增长，市场规模不断扩大，反映出人们对管理心臟健康的有效治疗方法的认识和需求不断增强。

技术进步：技术发展，特别是在个人化医疗领域，正在彻底改变他汀类药物市场。基因组学和生物资讯学的进步使更个人化的治疗方法成为可能，提高了他汀类药物的疗效并降低了不良反应的风险，从而推动了市场成长。

产业应用：他汀类药物主要用于医疗保健产业，透过降低低密度脂蛋白胆固醇水平来预防和治疗心血管疾病。它们的应用已成为管理心臟健康不可或缺的一部分，特别是在心臟病高风险族群。

主要市场趋势：他汀类药物市场的一个显着趋势是向精准医疗的转变，即根据个别基因谱量身订做治疗方法。此外，人们越来越关注预防性医疗保健措施，这推动了对他汀类药物作为心血管疾病预防药物的需求。

地理趋势：在人口老化和生活方式相关心臟病风险因素普遍存在的地区，对他汀类药物的需求尤其高。北美和欧洲等已开发地区目前主导市场，但由于健康意识的提高和医疗基础设施的改善，新兴经济体的需求不断增长。

竞争格局：全球市场的特征是存在多个关键参与者，竞争由创新、产品开发和行销策略驱动。市场也见证了製药公司和医疗保健提供者之间的合作，以提高他汀类药物治疗的可及性和有效性。

挑战与机会：市场的一项主要挑战是解决与他汀类药物使用相关的不良反应，这可能会影响患者的依从性。然而，这项挑战为开发副作用较少的新他汀类药物製剂提供了机会。此外，全球心血管疾病发生率的增加为市场扩张提供了巨大的机会。

他汀类药物市场趋势：

心血管疾病盛行率增加

心血管疾病（CVD）发生率的上升主要推动了全球市场的发展。他汀类药物以其降低胆固醇的特性而闻名，在心血管疾病的管理和预防中发挥关键作用。这种日益严重的健康负担导致人们对高低密度脂蛋白胆固醇等危险因子的认识不断增强并积极主动地进行管理。因此，这对市场有正面影响。因此，由于患者数量的增加和对预防性医疗保健的日益重视，对他汀类药物的需求不断增加。这种趋势在人口老化和生活方式相关危险因子的地区尤其明显，使他汀类药物成为心血管健康治疗和管理的关键组成部分。

个人化医疗的进步

个人化医疗的重大进步也推动了全球市场的发展。个人化或精准医学涉及根据每位患者的个别特征制定医疗治疗方案，就他汀类药物而言，这涉及考虑影响个人对这些药物反应的遗传因素。此外，研究表明，遗传变异会影响一个人对他汀类药物的反应，无论是在疗效还是副作用风险方面。因此，人们越来越关注开发优化他汀类药物治疗的个人化治疗计划。此外，基因组学和生物资讯学在医疗保健领域的整合是推动市场创新和成长的关键因素。

政府措施和医疗保健政策

政府措施和医疗保健政策对全球市场产生重大影响。世界各地许多政府正在实施政策和计划来应对不断上升的心臟病发病率。这些措施通常包括胆固醇管理指南，建议使用他汀类药物作为第一线治疗。此外，政府和医疗机构越来越关注预防性医疗措施，并认识到预防心臟病而不是事后治疗的成本效益。这种焦点的转变导致公共卫生活动的资金增加，提高了人们对胆固醇管理重要性的认识，从而推动了对他汀类药物的需求。此外，他汀类药物纳入国家和国际治疗指南进一步强调了其在心血管健康管理中的重要性，并促进了其在临床实践中的采用。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球他汀类药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 合成他汀类药物
    • 市场走向
    • 市场预测
  • 天然他汀类药物
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗领域

  • 心血管疾病
    • 市场走向
    • 市场预测
  • 肥胖
    • 市场走向
    • 市场预测
  • 发炎性疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依药物类别

  • 阿托伐他汀
    • 市场走向
    • 市场预测
  • 氟伐他汀
    • 市场走向
    • 市场预测
  • 洛伐他汀
    • 市场走向
    • 市场预测
  • 普伐他汀
    • 市场走向
    • 市场预测
  • 辛伐他汀
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 血脂异常
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依分布

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格指标

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott
    • AstraZeneca
    • Aurobindo Pharma
    • Biocon
    • GlaxoSmithKline
    • Merck & Co.
    • Novartis
    • Pfizer
Product Code: SR112024A1885

The global statin market size reached US$ 15.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases and hypercholesterolemia globally, the expanding healthcare infrastructure and the availability of insurance coverage for cholesterol-lowering medications bolster demand across the globe.

Statin Market Analysis:

Market Growth and Size: The global market is experiencing significant growth, driven largely by the increasing prevalence of cardiovascular diseases. With the rising demand for cholesterol-lowering drugs, the market size is expanding, reflecting a growing awareness and need for effective treatments in managing heart health.

Technological Advancements: Technological developments, particularly in the field of personalized medicine, are revolutionizing the statin market. Advances in genomics and bioinformatics are enabling more personalized treatment approaches, improving the efficacy of statins and reducing the risk of adverse effects, thus propelling market growth.

Industry Applications: Statins are primarily used in the healthcare industry for the prevention and treatment of cardiovascular diseases by lowering LDL cholesterol levels. Their application has become integral in managing heart health, especially in populations with high risk of heart diseases.

Key Market Trends: A notable trend in the statin market is the shift towards precision medicine, where treatments are tailored to individual genetic profiles. Additionally, there is an increasing focus on preventive healthcare measures, which is driving the demand for statins as a preventive medication for cardiovascular diseases.

Geographical Trends: The demand for statins is particularly high in regions with aging populations and those with prevalent lifestyle-related risk factors for heart diseases. Developed regions such as North America and Europe currently dominate the market, but there is a growing demand in emerging economies due to increasing health awareness and improving healthcare infrastructure.

Competitive Landscape: The global market is characterized by the presence of several key players, with competition driven by innovation, product development, and marketing strategies. The market is also witnessing collaborations between pharmaceutical companies and healthcare providers to enhance the accessibility and effectiveness of statin therapy.

Challenges and Opportunities: One major challenge in the market is addressing the adverse effects associated with statin use, which can affect patient compliance. However, this challenge presents an opportunity for the development of new statin formulations with fewer side effects. Additionally, the increasing incidence of cardiovascular diseases globally offers a substantial opportunity for market expansion.

Statin Market Trends:

Increasing prevalence of cardiovascular diseases

The rising incidence of cardiovascular diseases (CVDs) majorly drives the global market. Statins, known for their cholesterol-lowering properties, play a critical role in the management and prevention of CVDs. This growing health burden is leading to a growing awareness and proactive management of risk factors such as high LDL cholesterol. Therefore, this is positively influencing the market. Consequently, the demand for statins is escalating, driven by both the increasing number of patients and the growing emphasis on preventive healthcare. This trend is particularly noticeable in regions with aging populations and lifestyle-related risk factors, making statins a key component in the treatment and management of cardiovascular health.

Advancements in personalized medicine

The global market is also being propelled forward by significant advancements in personalized medicine. Personalized, or precision, medicine involves tailoring medical treatment to the individual characteristics of each patient, and in the case of statins, this involves considering genetic factors that affect an individual's response to these drugs. Additionally, research has shown that genetic variations can influence a person's response to statins, both in terms of efficacy and risk of side effects. As a result, there is an increasing focus on developing personalized treatment plans that optimize statin therapy. In addition, the integration of genomics and bioinformatics in healthcare is thus a key factor driving innovation and growth in the market.

Government initiatives and healthcare policies

Government initiatives and healthcare policies significantly influence the global market. Many governments across the world are implementing policies and programs to combat the rising incidence of heart disease. These initiatives often include guidelines for cholesterol management, which recommend the use of statins as a first-line therapy. Moreover, governments and healthcare organizations are increasingly focusing on preventive healthcare measures, recognizing the cost-effectiveness of preventing heart diseases rather than treating them post-occurrence. This shift in focus is leading to increased funding for public health campaigns that raise awareness about the importance of cholesterol management, thereby driving the demand for statins. Additionally, the inclusion of statins in national and international treatment guidelines further underscores their importance in cardiovascular health management and boosts their adoption in clinical practice.

Statin Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, therapeutic area, drug class, application, and distribution.

Breakup by Type:

Synthetic Statins

Natural Statins

Natural statins account for the majority of the market share

The report has provided a detailed breakup and analysis of the statin market based on the type. This includes synthetic statins and natural statins. According to the report, natural statins represented the largest segment.

Breakup by Therapeutic Area:

Cardiovascular Disorders

Obesity

Inflammatory Disorders

Others

A detailed breakup and analysis of the statin market based on the therapeutic area has also been provided in the report. This includes cardiovascular disorders, obesity, inflammatory disorders, and others.

Breakup by Drug Class:

Atorvastatin

Fluvastatin

Lovastatin

Pravastatin

Simvastatin

Others

Atorvastatin represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, and others. According to the report, atorvastatin accounted for the largest market share.

Breakup by Application:

Dyslipidemia

Others

A detailed breakup and analysis of the statin market based on the application has also been provided in the report. This includes dyslipidemia and others.

Breakup by Distribution:

Hospitals

Clinics

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution. This includes hospitals, clinics, and others. According to the report, hospitals accounted for the largest market share.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest statin market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AstraZeneca

Aurobindo Pharma

Biocon

GlaxoSmithKline

Merck & Co.

Novartis

Pfizer

Key Questions Answered in This Report

  • 1. What was the size of the global statin market in 2023?
  • 2. What is the expected growth rate of the global statin market during 2024-2032?
  • 3. What are the key factors driving the global statin market?
  • 4. What has been the impact of COVID-19 on the global statin market?
  • 5. What is the breakup of the global statin market based on the type?
  • 6. What is the breakup of the global statin market based on the drug class?
  • 7. What is the breakup of the global statin market based on the distribution?
  • 8. What are the key regions in the global statin market?
  • 9. Who are the key players/companies in the global statin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Statin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Synthetic Statins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Natural Statins
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Cardiovascular Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obesity
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inflammatory Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Atorvastatin
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluvastatin
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lovastatin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pravastatin
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Simvastatin
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Dyslipidemia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Others
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Distribution

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Italy
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Russia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 Japan
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 India
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Indonesia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 AstraZeneca
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Aurobindo Pharma
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Biocon
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Merck & Co.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Novartis
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Pfizer
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Statin Market: Major Drivers and Challenges
  • Figure 2: Global: Statin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Statin Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Statin Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 5: Global: Statin Market: Breakup by Drug Class (in %), 2023
  • Figure 6: Global: Statin Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Statin Market: Breakup by Distribution (in %), 2023
  • Figure 8: Global: Statin Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Statin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Statin (Synthetic Statins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Statin (Synthetic Statins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Statin (Natural Statins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Statin (Natural Statins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Statin (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Statin (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Statin (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Statin (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Statin (Inflammatory disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Statin (Inflammatory disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Statin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Statin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Statin (Atorvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Statin (Atorvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Statin (Fluvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Statin (Fluvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Statin (Lovastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Statin (Lovastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Statin (Pravastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Statin (Pravastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Statin (Simvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Statin (Simvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Statin (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Statin (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Statin (Dyslipidemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Statin (Dyslipidemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Statin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Statin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Statin (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Statin (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Statin (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Statin (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Statin (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Statin (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia Pacific: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia Pacific: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Statin Industry: SWOT Analysis
  • Figure 93: Global: Statin Industry: Value Chain Analysis
  • Figure 94: Global: Statin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Statin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Statin Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Statin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 4: Global: Statin Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 5: Global: Statin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Statin Market Forecast: Breakup by Distribution (in Million US$), 2024-2032
  • Table 7: Global: Statin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Statin Market: Competitive Structure
  • Table 9: Global: Statin Market: Key Players